Inicio › Cáncer de endometrio › Alabama › Birmingham
Ensayos clínicos de Cáncer de endometrio en Birmingham, AL
16 estudios para Cáncer de endometrio buscan participantes en centros de Birmingham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
ReclutandoFase 3
- GSK Investigational Site, Birmingham
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ReclutandoFase 3
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
ReclutandoFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
DESTINY-PANTUMOUR04
ReclutandoEstudio observacional
- Research Site, Birmingham
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
ReclutandoFase 1/2
- University of Alabama_6th Ave, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutandoEstudio observacional
- University of Alabama at Birmingham, Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- University of Alabama Birmingham, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Children's Hospital of Alabama, Birmingham
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Alabama at Birmingham, Birmingham
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Alabama at Birmingham, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
ReclutandoFase 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- y 1 más
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 004, Birmingham
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
ReclutandoFase 1/2
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Birmingham
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX68 estudios
- New York City, NY52 estudios
- Boston, MA50 estudios
- Arlington, VA39 estudios
- Nashville, TN38 estudios
- Los Angeles, CA34 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA28 estudios
- San Antonio, TX27 estudios
- Chicago, IL25 estudios
- Columbus, OH25 estudios
- Queens, NY25 estudios
Otros estudios en Birmingham
- Cáncer (todos los tipos)30 estudios
- Cáncer de seno24 estudios
- Obesidad23 estudios
- Cáncer de ovario23 estudios
- Cáncer de pulmón de células no pequeñas22 estudios
- Leucemia mielógena aguda21 estudios
- Mieloma múltiple18 estudios
- Enfermedad de obstrucción pulmonar crónica17 estudios
- Enfermedad cardiovascular17 estudios
- Sobrepeso16 estudios
- Diabetes tipo 216 estudios
- Fibrosis quística16 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.